Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Deferred Taxes: 2016-2021

Historic Deferred Taxes for Assembly Biosciences (ASMB) over the last 5 years, with Dec 2021 value amounting to -$2.5 million.

  • Assembly Biosciences' Deferred Taxes fell 167.28% to -$767,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$800,000, marking a year-over-year increase of 89.87%. This contributed to the annual value of -$2.5 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Assembly Biosciences reported Deferred Taxes of -$2.5 million as of FY2021, which was down 216.37% from -$800,000 recorded in FY2019.
  • In the past 5 years, Assembly Biosciences' Deferred Taxes registered a high of $1.1 million during FY2018, and its lowest value of -$9.1 million during FY2017.
  • Moreover, its 2-year median value for Deferred Taxes was -$1.7 million (2019), whereas its average is -$1.7 million.
  • As far as peak fluctuations go, Assembly Biosciences' Deferred Taxes slumped by 1,372.49% in 2017, and later spiked by 112.09% in 2018.
  • Over the past 4 years, Assembly Biosciences' Deferred Taxes (Yearly) stood at -$9.1 million in 2017, then surged by 112.09% to $1.1 million in 2018, then crashed by 172.73% to -$800,000 in 2019, then reached -$2.5 million in 2021.